MannKind Corp (MNKD)
4.225
+0.04
(+1.08%)
USD |
NASDAQ |
Apr 26, 16:00
4.225
0.00 (0.00%)
After-Hours: 20:00
MannKind Enterprise Value: 1.104B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 1.104B |
April 24, 2024 | 1.107B |
April 23, 2024 | 1.099B |
April 22, 2024 | 1.085B |
April 19, 2024 | 1.104B |
April 18, 2024 | 1.077B |
April 17, 2024 | 1.082B |
April 16, 2024 | 1.069B |
April 15, 2024 | 1.088B |
April 12, 2024 | 1.096B |
April 11, 2024 | 1.136B |
April 10, 2024 | 1.120B |
April 09, 2024 | 1.174B |
April 08, 2024 | 1.204B |
April 05, 2024 | 1.174B |
April 04, 2024 | 1.139B |
April 03, 2024 | 1.172B |
April 02, 2024 | 1.139B |
April 01, 2024 | 1.147B |
March 28, 2024 | 1.199B |
March 27, 2024 | 1.226B |
March 26, 2024 | 1.301B |
March 25, 2024 | 1.299B |
March 22, 2024 | 1.304B |
March 21, 2024 | 1.261B |
Date | Value |
---|---|
March 20, 2024 | 1.277B |
March 19, 2024 | 1.236B |
March 18, 2024 | 1.223B |
March 15, 2024 | 1.182B |
March 14, 2024 | 1.190B |
March 13, 2024 | 1.215B |
March 12, 2024 | 1.177B |
March 11, 2024 | 1.220B |
March 08, 2024 | 1.399B |
March 07, 2024 | 1.366B |
March 06, 2024 | 1.272B |
March 05, 2024 | 1.258B |
March 04, 2024 | 1.231B |
March 01, 2024 | 1.190B |
February 29, 2024 | 1.085B |
February 28, 2024 | 1.034B |
February 27, 2024 | 995.78M |
February 26, 2024 | 941.70M |
February 23, 2024 | 933.58M |
February 22, 2024 | 944.40M |
February 21, 2024 | 947.11M |
February 20, 2024 | 947.11M |
February 16, 2024 | 960.63M |
February 15, 2024 | 975.43M |
February 14, 2024 | 945.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
247.88M
Minimum
Jun 26 2019
1.593B
Maximum
Aug 08 2023
910.29M
Average
1.047B
Median
Enterprise Value Benchmarks
NovaBay Pharmaceuticals Inc | 2.275M |
Palatin Technologies Inc | 18.27M |
iBio Inc | 15.86M |
Theriva Biologics Inc | -13.19M |
Oragenics Inc | 3.172M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 1.401M |
Revenue (Quarterly) | 58.47M |
Total Expenses (Quarterly) | 47.84M |
EPS Diluted (Quarterly) | 0.01 |
Gross Profit Margin (Quarterly) | 69.10% |
Profit Margin (Quarterly) | 2.40% |
Earnings Yield | -0.95% |
Operating Earnings Yield | 0.89% |
Normalized Earnings Yield | -0.8039 |